A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03976401 · COMPLETED
Trial details
- NCT number
- NCT03976401
- Sponsor
- Akero Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-28
- Primary completion
- 2021-02-10
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.